Abstract
A growing number of interspinous process devices are currently under evaluation for use in the management of lumbar degenerative disease. Although some clinical and biomechanical evidence exists for several of these devices, their individual indications of use and effectiveness are still in the early stages of investigation. The only FDA-approved device available at present is the X-Stop (Kyphon, Inc., Sunnyvale, CA; Medtronic, Memphis, TN), which has indications for use in the management of neurogenic claudication resulting from lumbar stenosis. In this review, we highlight the role of these devices in the management of lumbar spine disease, their proposed mechanisms of action, and areas for future development.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
